fbpx

Actavis to acquire Allergan

Actavis and Allergan announced that they have entered into a definitive agreement under which Actavis will acquire Allergan.

Actavis will pay $129.22 US in cash plus Actavis shares for each share of Allergan common stock. Based on the closing price of Actavis shares on November 14, 2014, the transaction is valued at approximately $66 billion, or $219 per Allergan share.

The transaction has been unanimously approved by the boards of directors of both companies and is supported by the two management teams. This consequently puts an end to Valeant’s attempt to take over Allergan that began several months ago and about which much has been written.

The two companies combined will create one of the top 10 global growth pharmaceuticals with expected revenue of $23 billion in 2015. This deal should close in the second quarter of 2015.

For further details on the transaction: http://agn.client.shareholder.com/releasedetail.cfm?ReleaseID=883356

Featured Posts

Optometry Giving Sight logo a turquoise eye with black icons in the shape of people for the iris

Optometry Giving Sight’s Grant Process Begins March 1

Optometry Giving Sight (OGS) will begin accepting pre-applications for its grant program that funds sustainable, optometry-based projects to end preventable blindness and vision impairment throughout the world.

Learn More

CSI Dry Eye Software Announces the Appointment of Trudi Charest as Chief Sales Officer

CSI Dry Eye Software, an emerging AI dry eye software company at the forefront of pioneering artificial intelligence in dry eye diagnostics and treatment recommendations, announces that it has appointed Trudi Charest as CSO – Chief Sales Officer.

Read more

SightGlass Vision Receives Breakthrough Device Designation from U.S. FDA

SightGlass Vision announced that the FDA has granted Breakthrough Device designation to its Diffusion Optics Technology™ (DOT™) spectacle lenses.

Read more

Vitamin A Supplements do not Improve Vision for Individuals with Retinitis Pigmentosa

A new study from Dr. Eric Pierce and Dr. Jason Comander at Mass Eye and Ear does not show any benefit to taking high-dose vitamin A supplements for people with retinitis pigmentosa (RP).

Read more

Custom Lamination Meets Unmatched Style

Featuring a modified round shape with subtly pointed, thoughtfully thickened upper corners, the Fysh F-3725 col. S412 acetate frame radiates sophistication while accentuating the distinctive contours of this eyewear masterpiece.

Read more
Optometry Giving Sight logo a turquoise eye with black icons in the shape of people for the iris

Optometry Giving Sight’s Grant Process Begins March 1

Optometry Giving Sight (OGS) will begin accepting pre-applications for its grant program that funds sustainable, optometry-based projects to end preventable blindness and vision impairment throughout the world.

Learn More

CSI Dry Eye Software Announces the Appointment of Trudi Charest as Chief Sales Officer

CSI Dry Eye Software, an emerging AI dry eye software company at the forefront of pioneering artificial intelligence in dry eye diagnostics and treatment recommendations, announces that it has appointed Trudi Charest as CSO – Chief Sales Officer.

Read More

SightGlass Vision Receives Breakthrough Device Designation from U.S. FDA

SightGlass Vision announced that the FDA has granted Breakthrough Device designation to its Diffusion Optics Technology™ (DOT™) spectacle lenses.

Read More

Vitamin A Supplements do not Improve Vision for Individuals with Retinitis Pigmentosa

A new study from Dr. Eric Pierce and Dr. Jason Comander at Mass Eye and Ear does not show any benefit to taking high-dose vitamin A supplements for people with retinitis pigmentosa (RP).

Read More

Custom Lamination Meets Unmatched Style

Featuring a modified round shape with subtly pointed, thoughtfully thickened upper corners, the Fysh F-3725 col. S412 acetate frame radiates sophistication while accentuating the distinctive contours of this eyewear masterpiece.

Read More
Optometry Giving Sight logo a turquoise eye with black icons in the shape of people for the iris

Optometry Giving Sight’s Grant Process Begins March 1

Optometry Giving Sight (OGS) will begin accepting pre-applications for its grant program that funds sustainable, optometry-based projects to end preventable blindness and vision impairment throughout the world.

Learn More

CSI Dry Eye Software Announces the Appointment of Trudi Charest as Chief Sales Officer

CSI Dry Eye Software, an emerging AI dry eye software company at the forefront of pioneering artificial intelligence in dry eye diagnostics and treatment recommendations, announces that it has appointed Trudi Charest as CSO – Chief Sales Officer.

Read more

SightGlass Vision Receives Breakthrough Device Designation from U.S. FDA

SightGlass Vision announced that the FDA has granted Breakthrough Device designation to its Diffusion Optics Technology™ (DOT™) spectacle lenses.

Read more

Vitamin A Supplements do not Improve Vision for Individuals with Retinitis Pigmentosa

A new study from Dr. Eric Pierce and Dr. Jason Comander at Mass Eye and Ear does not show any benefit to taking high-dose vitamin A supplements for people with retinitis pigmentosa (RP).

Read more

Custom Lamination Meets Unmatched Style

Featuring a modified round shape with subtly pointed, thoughtfully thickened upper corners, the Fysh F-3725 col. S412 acetate frame radiates sophistication while accentuating the distinctive contours of this eyewear masterpiece.

Read more
Optometry Giving Sight logo a turquoise eye with black icons in the shape of people for the iris

Optometry Giving Sight’s Grant Process Begins March 1

Optometry Giving Sight (OGS) will begin accepting pre-applications for its grant program that funds sustainable, optometry-based projects to end preventable blindness and vision impairment throughout the world.

Learn More

CSI Dry Eye Software Announces the Appointment of Trudi Charest as Chief Sales Officer

CSI Dry Eye Software, an emerging AI dry eye software company at the forefront of pioneering artificial intelligence in dry eye diagnostics and treatment recommendations, announces that it has appointed Trudi Charest as CSO – Chief Sales Officer.

Read more

SightGlass Vision Receives Breakthrough Device Designation from U.S. FDA

SightGlass Vision announced that the FDA has granted Breakthrough Device designation to its Diffusion Optics Technology™ (DOT™) spectacle lenses.

Read more

Vitamin A Supplements do not Improve Vision for Individuals with Retinitis Pigmentosa

A new study from Dr. Eric Pierce and Dr. Jason Comander at Mass Eye and Ear does not show any benefit to taking high-dose vitamin A supplements for people with retinitis pigmentosa (RP).

Read more

Custom Lamination Meets Unmatched Style

Featuring a modified round shape with subtly pointed, thoughtfully thickened upper corners, the Fysh F-3725 col. S412 acetate frame radiates sophistication while accentuating the distinctive contours of this eyewear masterpiece.

Read more